Hedge Fund - HighVista Strategies
Viridian Therapeutics Inc. ()
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q2 (2025-06-30) | $6,774,135 | 2.49% | 484,559 | $ |
2 | 2025 - Q1 (2025-03-31) | $2,433,827 | 0.94% | 180,551 | $ |
3 | 2024 - Q4 (2024-12-31) | $2,962,973 | 1.1% | 154,563 | $ |
4 | 2024 - Q3 (2024-09-30) | $4,214,210 | 1.45% | 185,240 | $ |
5 | 2024 - Q2 (2024-06-30) | $2,582,277 | 0.94% | 198,484 | $ |
6 | 2024 - Q1 (2024-03-31) | $3,475,455 | 1.23% | 198,484 | $ |
7 | 2023 - Q4 (2023-12-31) | $4,322,982 | 1.56% | 198,484 | $ |
8 | 2023 - Q3 (2023-09-30) | $1,606,957 | 0.74% | 104,756 | $ |
9 | 2023 - Q2 (2023-06-30) | $2,587,519 | 1.18% | 108,765 | $ |
10 | 2023 - Q1 (2023-03-31) | $2,414,485 | 1.96% | 94,909 | $ |
11 | 2022 - Q4 (2022-12-31) | $2,920,474 | 1.73% | 99,982 | $ |
12 | 2022 - Q3 (2022-09-30) | $2,100,000 | 1.19% | 102,372 | $ |
13 | 2022 - Q2 (2022-06-30) | $521,000 | 0.31% | 45,039 | $ |
14 | 2022 - Q1 (2022-03-31) | $907,000 | 0.57% | 49,065 | $ |
The displayed share prices are average quarterly stock market prices.